Integrated Filing — IndAS

General information about company
Scrip Code	543896
NSE Symbol	AVALON
MSEI Symbol	NOTLISTED
ISIN	INE0LCL01028
Name of company	Avalon Technologies Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	06-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	28-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Electronics Manufacturing Services
Start date and time of board meeting	06-May-2025   18:00:00
End date and time of board meeting	06-May-2025   20:00:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	3427870000	10981280000
	Other income	31770000	171060000
	Total income	3459640000	11152340000
2	Expenses
(a)	Cost of materials consumed	2235540000	7187850000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-10450000	-133170000
(d)	Employee benefit expense	569960000	1985510000
(e)	Finance costs	42310000	167040000
(f)	Depreciation, depletion and amortisation expense	77260000	285690000
(f)	Other Expenses
1	Other Expenses	219280000	792290000
	Total other expenses	219280000	792290000
	Total expenses	3133900000	10285210000
3	Total profit before exceptional items and tax	325740000	867130000
4	Exceptional items	0	0
5	Total profit before tax	325740000	867130000
6	Tax expense
7	Current tax	54720000	203660000
8	Deferred tax	28250000	29080000
9	Total tax expenses	82970000	232740000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	242770000	634390000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	242770000	634390000
17	Other comprehensive income net of taxes	7310000	-17120000
18	Total Comprehensive Income for the period	250080000	617270000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	242770000	634390000
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	250080000	617270000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	132310000	132310000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		5983160000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	3.67	9.62
	Diluted earnings (loss) per share from continuing operations	3.63	9.48
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	3.67	9.62
	Diluted earnings (loss) per share from continuing and discontinued operations	3.63	9.48
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	1473750000
	Capital work-in-progress	103990000
	Investment property
	Goodwill	0
	Other intangible assets	42080000
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	17770000
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets	56650000
	Total non-current financial assets	74420000
	Deferred tax assets (net)	156060000
	Other non-current assets	381590000
	Total non-current assets	2231890000
2	Current assets
	Inventories	3378990000
	Current financial asset
	Current investments	331710000
	Trade receivables, current	3160050000
	Cash and cash equivalents	688270000
	Bank balance other than cash and cash equivalents	327110000
	Loans, current	0
	Other current financial assets	5330000
	Total current financial assets	4512470000
	Current tax assets (net)
	Other current assets	275410000
	Total current assets	8166870000
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	10398760000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	132310000
	Other equity	5983160000
	Total equity attributable to owners of parent	6115470000
	Non controlling interest
	Total equity	6115470000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	183540000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities	292100000
	Total non-current financial liabilities	475640000
	Provisions, non-current	102560000
	Deferred tax liabilities (net)	18660000
	Deferred government grants, Non-current
	Other non-current liabilities
	Total non-current liabilities	596860000
	Current liabilities
	Current financial liabilities
	Borrowings, current	1233160000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	15220000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1878310000
	Total Trade payable	1893530000
	Other current financial liabilities	256860000
	Total current financial liabilities	3383550000
	Other current liabilities	256090000
	Provisions, current	46790000
	Current tax liabilities (Net)
	Deferred government grants, Current
	Total current liabilities	3686430000
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	4283290000
	Total equity and liabilites	10398760000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurements of the defined benefit plans - Gratuity	7480000	-1290000
2	Fair value changes on Equity Instruments through other comprehensive income	10000	11750000
	Total Amount of items that will not be reclassified to profit and loss	7490000	10460000
2	Income tax relating to items that will not be reclassified to profit or loss	1950000	2830000
3	Amount of items that will be reclassified to profit and loss
1	Exchange differences in translating the financial statements of foreign operations	1770000	-24750000
	Total Amount of items that will be reclassified to profit and loss	1770000	-24750000
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	7310000	-17120000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			867130000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			142800000
	Adjustments for decrease (increase) in inventories			-201290000
	Adjustments for decrease (increase) in trade receivables, current			-1290690000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			0
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			-51630000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			839200000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			285690000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			-42950000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			-135260000
	Adjustments for other financial liabilities, non-current			34830000
	Adjustments for unrealised foreign exchange losses gains			48230000
	Adjustments for dividend income			-24240000
	Adjustments for interest income			48770000
	Adjustments for share-based payments			9330000
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			-36240000
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-422510000
	Net cash flows from (used in) operations			444620000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			194060000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			250560000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			5880000
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			461790000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			961250000
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			44400000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	537980000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			374580000
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			15470000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			121690000
	Repayments of borrowings			0
	Payments of lease liabilities			122820000
	Dividends paid			52080000
	Interest paid			110520000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-522840000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			265700000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			-830000
	Net increase (decrease) in cash and cash equivalents			264870000
	Cash and cash equivalents cash flow statement at beginning of period			423400000
	Cash and cash equivalents cash flow statement at end of period			688270000